No Detail Found!

Unmasking pustular psoriasis subsequent to COVID-19

Author(s)
Ronak Miladi Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
Alireza Janbakhsh Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
Arefeh Babazadeh Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.
Zeinab Aryanian Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Soheil Ebrahimpour Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.
Zeinab Mohseni Afshar Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences,Kermanshah,Iran
Abstract
Various cutaneous manifestations have recently appeared within context of 2019 novel coronavirus diseases (COVID-19). Currently, outbreaks of psoriasis were reported during COVID-19. We reported a case of a 32-year-old woman with COVID-19 who presented with pustular psoriasis. She was treated with oral prednisolone, hydroxyzine and topical clobetasol. The two-week follow-up revealed that her lesions were desquamating and that she was in a favorable situation. The current report will highlight specific skin manifestations of COVID-19, allowing clinicians to further confirm our suspicions.
Publication Details
Page(s) 526-529
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 31, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
COVID-19, Azithromycin, Hydroxychloroquine, Pustular psoriasis
0

Citations

0

Downloads

41

Views